Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Colorectal Cancer

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Wayne Hospital
mi
from
Greenville, OH
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Wayne Hospital
mi
from
Greenville, OH
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Charles F. Kettering Memorial Hospital
mi
from
Kettering, OH
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Charles F. Kettering Memorial Hospital
mi
from
Kettering, OH
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
UVMC Cancer Care Center at Upper Valley Medical Center
mi
from
Troy, OH
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
UVMC Cancer Care Center at Upper Valley Medical Center
mi
from
Troy, OH
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Clinton Memorial Hospital
mi
from
Wilmington, OH
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Clinton Memorial Hospital
mi
from
Wilmington, OH
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Ruth G. McMillan Cancer Center at Greene Memorial Hospital
mi
from
Xenia, OH
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Ruth G. McMillan Cancer Center at Greene Memorial Hospital
mi
from
Xenia, OH
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Integris Oncology Services
mi
from
Oklahoma City, OK
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Integris Oncology Services
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Natalie Warren Bryant Cancer Center at St. Francis Hospital
mi
from
Tulsa, OK
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Natalie Warren Bryant Cancer Center at St. Francis Hospital
mi
from
Tulsa, OK
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Providence Cancer Center at Providence Portland Medical Center
mi
from
Portland, OR
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Providence Cancer Center at Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Knight Cancer Institute at Oregon Health and Science University
mi
from
Portland, OR
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Knight Cancer Institute at Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
mi
from
Allentown, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
mi
from
Allentown, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
UPMC Cancer Center at Beaver Medical Center
mi
from
Beaver, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
UPMC Cancer Center at Beaver Medical Center
mi
from
Beaver, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
UPMC Cancer Center at Jefferson Regional Medical Center
mi
from
Clairton, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
UPMC Cancer Center at Jefferson Regional Medical Center
mi
from
Clairton, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
UPMC Cancer Center - Arnold Palmer Pavilion
mi
from
Greensburg, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
UPMC Cancer Center - Arnold Palmer Pavilion
mi
from
Greensburg, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Penn State Cancer Institute at Milton S. Hershey Medical Center
mi
from
Hershey, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Penn State Cancer Institute at Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
UPMC Cancer Center at the John P. Murtha Pavilion
mi
from
Johnstown, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
UPMC Cancer Center at the John P. Murtha Pavilion
mi
from
Johnstown, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
UPMC Cancer Center - Natrona Heights
mi
from
Natrona Heights, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
UPMC Cancer Center - Natrona Heights
mi
from
Natrona Heights, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Jameson Memorial Hospital - North Campus
mi
from
New Castle, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Jameson Memorial Hospital - North Campus
mi
from
New Castle, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Fox Chase Cancer Center - Philadelphia
mi
from
Philadelphia, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Fox Chase Cancer Center - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Allegheny Cancer Center at Allegheny General Hospital
mi
from
Pittsburgh, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Allegheny Cancer Center at Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
UPMC - Shadyside
mi
from
Pittsburgh, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
UPMC - Shadyside
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
UPMC Cancer Center at Magee-Womens Hospital
mi
from
Pittsburgh, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
UPMC Cancer Center at Magee-Womens Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
UPMC Cancer Center at UPMC Presbyterian
mi
from
Pittsburgh, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
UPMC Cancer Center at UPMC Presbyterian
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
UPMC Cancer Center at UPMC St. Margaret
mi
from
Pittsburgh, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
UPMC Cancer Center at UPMC St. Margaret
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
mi
from
Pittsburgh, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
UPMC Cancer Centers
mi
from
Pittsburgh, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
UPMC Cancer Centers
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
UPMC Cancer Center at UPMC Passavant
mi
from
Pittsburgh, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
UPMC Cancer Center at UPMC Passavant
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
St. Clair Memorial Hospital Cancer Center
mi
from
Pittsburgh, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
St. Clair Memorial Hospital Cancer Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
UPMC Cancer Center at UPMC Northwest
mi
from
Seneca, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
UPMC Cancer Center at UPMC Northwest
mi
from
Seneca, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Washington Hospital Cancer Center
mi
from
Washington, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Washington Hospital Cancer Center
mi
from
Washington, PA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
M. D. Anderson Cancer Center at University of Texas
mi
from
Houston, TX
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
M. D. Anderson Cancer Center at University of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Methodist Hospital
mi
from
Houston, TX
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Surgical Oncology Associates
mi
from
Newport News, VA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Surgical Oncology Associates
mi
from
Newport News, VA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Providence Cancer Center at Sacred Heart Medical Center
mi
from
Spokane, WA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Providence Cancer Center at Sacred Heart Medical Center
mi
from
Spokane, WA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Providence Cancer Center at Holy Family Hospital
mi
from
Spokane, WA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Providence Cancer Center at Holy Family Hospital
mi
from
Spokane, WA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
United Hospital Center
mi
from
Clarksburg, WV
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
United Hospital Center
mi
from
Clarksburg, WV
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Edwards Comprehensive Cancer Center at Cabell Huntington Hospital
mi
from
Huntington, WV
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Edwards Comprehensive Cancer Center at Cabell Huntington Hospital
mi
from
Huntington, WV
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
mi
from
Madison, WI
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
UPMC - Moon
mi
from
Moon, PA
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
UPMC - Moon
mi
from
Moon, PA
Click here to add this to my saved trials
Mindfulness Meditation Intervention for Colorectal Cancer Patients and Caregivers
Being Present: Audio-Based Mindfulness Meditation Intervention for Colorectal Cancer Patients and Caregivers
Status: Enrolling
Updated:  2/22/2018
University of California at San Francisco
mi
from
San Francisco, CA
Mindfulness Meditation Intervention for Colorectal Cancer Patients and Caregivers
Being Present: Audio-Based Mindfulness Meditation Intervention for Colorectal Cancer Patients and Caregivers
Status: Enrolling
Updated: 2/22/2018
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer
Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer
Status: Enrolling
Updated:  2/23/2018
Johns Hopkins Hospital
mi
from
Baltimore, MD
Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer
Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer
Status: Enrolling
Updated: 2/23/2018
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
mi
from
PARK Springs, AZ
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
mi
from
PARK Springs, AZ
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Sedona, AZ
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Sedona, AZ
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Tucson, AZ
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Anaheim, CA
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Colton, CA
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Colton, CA
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Greenbrae, CA
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Greenbrae, CA
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Loma Linda, CA
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Loma Linda, CA
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Modesto, CA
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Modesto, CA
Click here to add this to my saved trials
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Montebello, CA
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
A Randomized, Open Label Study of the Effect of First Line Treatment With Xeloda in Combination With Avastin and Either Short Course Irinotecan or Short Course Oxaliplatin on Progression-free Survival in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Montebello, CA
Click here to add this to my saved trials